DCAI
CAS No. 299165-92-7
DCAI( —— )
Catalog No. M27763 CAS No. 299165-92-7
DCAI is an inhibitor of nucleotide exchange and nucleotide release acting by binding to the pocket adjacent to the Ras-SOS interface.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 188 | In Stock |
|
| 5MG | 227 | In Stock |
|
| 10MG | 318 | In Stock |
|
| 25MG | 535 | In Stock |
|
| 50MG | 736 | In Stock |
|
| 100MG | 1042 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2093 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDCAI
-
NoteResearch use only, not for human use.
-
Brief DescriptionDCAI is an inhibitor of nucleotide exchange and nucleotide release acting by binding to the pocket adjacent to the Ras-SOS interface.
-
DescriptionDCAI is an inhibitor of nucleotide exchange and nucleotide release acting by binding to the pocket adjacent to the Ras-SOS interface.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptormTOR (FKBP12)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number299165-92-7
-
Formula Weight243.13
-
Molecular FormulaC11H12Cl2N2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1[nH]c2cc(Cl)cc(Cl)c2c1CCN
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Coix Seed oil Refere...
Coix Seed oil Reference Extract
-
[Pyr1]-Apelin-13
[Pyr1]-Apelin-13 is a potent and selective endogenous Apelin receptor (APJ) agonist.[Pyr1]-apelin-13 encapsulation in lipoPEG particles (lipoPEG-PA13) results in sustained and extended drug release under physiological conditions[1].[Pyr1]-apelin-13 nanocarriers in a mouse model of pressure-overload induced heart failure demonstrate a sustainable long-term effect of [Pyr1]-apelin-13 in preventing cardiac dysfunction.
-
JMJD6 inhibitor WL12
2H-1-Benzopyran-2-one, 3-(3H-imidazo[4,5-c]pyridin-2-yl)-6-methyl- is a first-in-class JMJD6 inhibitor and was shown to be able to suppress JMJD6-dependent cancer cell proliferation including cervical and liver cancer cells.
Cart
sales@molnova.com